Abstract C77: A novel BRCA2 targeting antisense oligonucleotide sensitizes human tumor cells to chemotherapy and radiotherapy - the induction of ‘complementary lethality’ by targeting DNA repair.
1988 ◽
pp. 173-182
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Keyword(s):
Keyword(s):
Keyword(s):
1985 ◽
Vol 31
(1-2)
◽
pp. 141-151
◽
2002 ◽
Vol 9
(1)
◽
pp. 2-9
◽